Rose Baker

3.1k total citations · 1 hit paper
19 papers, 2.3k citations indexed

About

Rose Baker is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Rose Baker has authored 19 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 7 papers in Virology and 7 papers in Emergency Medicine. Recurrent topics in Rose Baker's work include HIV/AIDS Research and Interventions (14 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (7 papers). Rose Baker is often cited by papers focused on HIV/AIDS Research and Interventions (14 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (7 papers). Rose Baker collaborates with scholars based in United States, Vietnam and Kenya. Rose Baker's co-authors include Kathleen C. Wood, John T. Brooks, Anne C. Moorman, Frank J. Palella, Joan S. Chmiel, Scott D. Holmberg, Kate Buchacz, Kenneth Lichtenstein, Richard M. Novak and Ellen Tedaldi and has published in prestigious journals such as Clinical Infectious Diseases, Journal of the American Geriatrics Society and AIDS.

In The Last Decade

Rose Baker

19 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mortality in the Highly Active Antiretroviral Therapy Era

2006 1.1k citations Frank J. Palella, Rose Baker et al. JAIDS Journal of Acquired Immune Deficiency Syndromes profile →

Peers

Countries citing papers authored by Rose Baker

Since Specialization

Citations

This map shows the geographic impact of Rose Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Baker more than expected).

Fields of papers citing papers by Rose Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Baker. The network helps show where Rose Baker may publish in the future.

Co-authorship network of co-authors of Rose Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Rose Baker. A scholar is included among the top collaborators of Rose Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose Baker. Rose Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Antiretroviral Regimen Durability and Success in Treatment-Naive and Treatment-Experienced Patients by Year of Treatment Initiation, United States, 1996–2011 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Anandi N. Sheth, Ighovwerha Ofotokun, Kate Buchacz, Carl Armon, Joan S. Chmiel, Rachel Hart, Rose Baker, John T. Brooks, Frank J. Palella	19
2	Is Primary Mycobacterium avium Complex Prophylaxis Necessary in Patients with CD4 <50 Cells/μL Who Are Virologically Suppressed on cART? 2014 ·AIDS Patient Care and STDs ·Bienvenido G. Yangco, Kate Buchacz, Rose Baker, Frank J. Palella, Carl Armon, John T. Brooks, (unknown)	16
3	Disparities in Prevalence of Key Chronic Diseases by Gender and Race/Ethnicity among Antiretroviral-Treated HIV-Infected Adults in the Us 2012 ·Antiviral Therapy ·Kate Buchacz, Rose Baker, Frank J. Palella, Lauren Shaw, Pragna Patel, Kenneth Lichtenstein, Joan S. Chmiel, Claudia Vellozzi, (unknown), Keith Henry, Edgar T. Overton, Timothy J. Bush, Ellen Tedaldi, Charles C. J. Carpenter, Kenneth H. Mayer, John T. Brooks, (unknown)	81
4	Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999–2008 2012 ·AIDS Research and Treatment ·Kate Buchacz, Rose Baker, Douglas Ward, Frank J. Palella, Joan S. Chmiel, Benjamin Young, Bienvenido G. Yangco, Richard Novák, John T. Brooks	8
5	Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment 2011 ·AIDS ·Frank J. Palella, Rose Baker, Kate Buchacz, Joan S. Chmiel, Ellen Tedaldi, Richard M. Novak, Marcus D. Durham, John T. Brooks	27
6	CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000–2009 2011 ·AIDS Research and Treatment ·Kate Buchacz, Carl Armon, Frank J. Palella, Rose Baker, Ellen Tedaldi, Marcus D. Durham, John T. Brooks	35
7	AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study 2010 ·AIDS ·Kate Buchacz, Rose Baker, Frank J. Palella, Joan S. Chmiel, Kenneth Lichtenstein, Richard M. Novak, Kathleen C. Wood, John T. Brooks	248
8	Changes in the Use of HIV Antiretroviral Resistance Testing in a Large Cohort of U.S. Patients, 1999 to 2006 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kate Buchacz, Rose Baker, Benjamin Young, John T. Brooks	7
9	Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994–2005 2008 ·AIDS ·Kate Buchacz, Rose Baker, Anne C. Moorman, James T. Richardson, Kathleen C. Wood, Scott D. Holmberg, John T. Brooks	114
10	Positive Fungal Cultures in Burn Patients: A Multicenter Review 2008 ·Journal of Burn Care & Research ·(unknown), Linda S. Edelman, Jeffrey R. Saffle, Robert L. Sheridan, Richard J. Kagan, David Bracco, Leopoldo C. Cancio, Bruce A. Cairns, Rose Baker, (unknown), Lucy Wibbenmeyer, (unknown), Tina L. Palmieri, David G. Greenhalgh, Nathan A. Kemalyan, Diego Caruso	116
11	Renal Function in Tenofovir-Exposed and Tenofovir-Unexposed Patients Receiving Highly Active Antiretroviral Therapy in the HIV Outpatient Study 2007 ·Journal of the International Association of Physicians in AIDS Care ·Benjamin Young, Kate Buchacz, Rose Baker, Anne C. Moorman, Kathy Wood, Joan S. Chmiel, John T. Brooks, (unknown)	47
12	HIV Genotypic Resistance Testing to Optimize Antiretroviral Prescribing: Is There Room for Improvement? 2007 ·Antiviral Therapy ·Jonathan Uy, John T. Brooks, Rose Baker, Mark A. Hoffman, Anne C. Moorman, Richard Novák, (unknown)	2
13	Short-Term Safety and Tolerability of Didanosine Combined with High- versus Low-Dose Tenofovir Disproxil Fumarate in Ambulatory HIV-1–Infected Persons 2006 ·AIDS Patient Care and STDs ·(unknown), Paul J. Weidle, Rose Baker, Carl Armon, Kathleen C. Wood, Anne C. Moorman, Scott D. Holmberg, (unknown)	5
14	Mortality in the Highly Active Antiretroviral Therapy Era breakdown → 2006 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Frank J. Palella, Rose Baker, Anne C. Moorman, Joan S. Chmiel, Kathleen C. Wood, John T. Brooks, Scott D. Holmberg	1105
15	Increased Body Mass Index Does Not Alter Response to Initial Highly Active Antiretroviral Therapy in HIV-1-Infected Patients 2006 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Ellen Tedaldi, John T. Brooks, Paul J. Weidle, James T. Richardson, Rose Baker, Kate Buchacz, Anne C. Moorman, Kathleen C. Wood, Scott D. Holmberg	20
16	The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy 2006 ·AIDS ·Jessica R. Grubb, Anne C. Moorman, Rose Baker, Henry Masur	67
17	Influence of Coinfection with Hepatitis C Virus on Morbidity and Mortality Due to Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy 2003 ·Clinical Infectious Diseases ·Ellen Tedaldi, Rose Baker, Anne C. Moorman, Carlos Alzola, (unknown), Robert E. McCabe, Kathleen C. Wood, Scott D. Holmberg, (unknown)	142
18	Prevalence and clinical correlates of HIV viremia (`blips') in patients with previous suppression below the limits of quantification 2002 ·AIDS ·Peter Sklar, Douglas Ward, Rose Baker, Kathleen C. Wood, (unknown), Carlos Alzola, Anne C. Moorman, Scott D. Holmberg	88
19	Family Satisfaction with End‐of‐Life Care in Seriously Ill Hospitalized Adults 2000 ·Journal of the American Geriatrics Society ·Rose Baker, (unknown), Albert W. Wu, Joan M. Teno, Barbara Kreling, (unknown), Haya R. Rubin, Mary Jo Roach, (unknown), Russell S. Phillips, Norman A. Desbiens, (unknown), William A. Knaus, Joanne Lynn	163

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact